Ngoc T Hoang
Overview
Explore the profile of Ngoc T Hoang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
359
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vo T, Hoang N, Nguyen T, Tran H, Trinh H
Cureus
. 2024 Nov;
16(10):e72235.
PMID: 39583482
Background Previously, fetuses with increased nuchal translucency (NT) were mainly tested for aneuploidy. Recent evidence has shown an incidence of other genetic disorders in euploidy fetuses with thickened NT. Chromosomal...
2.
Nishimoto K, Barca T, Azameera A, Makkouk A, Romero J, Bai L, et al.
Clin Transl Immunology
. 2022 Feb;
11(2):e1373.
PMID: 35136603
Objectives: Autologous chimeric antigen receptor (CAR) αβ T-cell therapies have demonstrated remarkable antitumor efficacy in patients with haematological malignancies; however, not all eligible cancer patients receive clinical benefit. Emerging strategies...
3.
Jeong Y, Hellyer J, Stehr H, Hoang N, Niu X, Das M, et al.
Clin Cancer Res
. 2019 Sep;
26(1):274-281.
PMID: 31548347
Purpose: Activation of NFE2L2 has been linked to chemoresistance in cell line models. Recently, somatic mutations that activate NFE2L2, including mutations in , or have been found to be associated...
4.
Hoang N, Acevedo L, Mann M, Tolani B
Cancer Manag Res
. 2018 May;
10:1089-1114.
PMID: 29785138
Soft-tissue sarcomas are rare malignant tumors arising from connective tissues and have an overall incidence of about five per 100,000 per year. While this diverse family of malignancies comprises over...
5.
Tolani B, Hoang N, Acevedo L, Giroux Leprieur E, Li H, He B, et al.
Oncotarget
. 2018 Mar;
9(18):14311-14323.
PMID: 29581846
The Sonic Hedgehog (Shh) signaling pathway has been implicated in the development and tumor progression of a number of human cancers. Using synthetic peptide mimics to mount an immune response,...
6.
Tolani B, Acevedo L, Hoang N, He B
Int J Mol Sci
. 2018 Jan;
19(1).
PMID: 29342862
Malignant pleural mesothelioma (MPM) tumors are remarkably aggressive and most patients only survive for 5-12 months; irrespective of stage; after primary symptoms appear. Compounding matters is that MPM remains unresponsive...
7.
Giroux Leprieur E, Tolani B, Li H, Leguay F, Hoang N, Acevedo L, et al.
Oncotarget
. 2017 Dec;
8(61):103744-103757.
PMID: 29262597
The mechanism of Sonic Hedgehog (Shh) pathway activation in non-small cell lung cancer (NSCLC) is poorly described. Using an antibody against the Shh C-terminal domain, we found a small population...
8.
Jeong Y, Hoang N, Lovejoy A, Stehr H, Newman A, Gentles A, et al.
Cancer Discov
. 2016 Sep;
7(1):86-101.
PMID: 27663899
Significance: We developed an LSCC mouse model involving Trp53 and Keap1, which are frequently mutated in human LSCCs. In this model, ABSCs are the cell of origin of these tumors....